Polypharmacy in people with Type 1 and Type 2 diabetes is justified by current guidelines-a comprehensive assessment of drug prescriptions in patients needing inpatient treatment for diabetes-associated problems

Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

(2012) S. E. Inzucchi et al.   DIABETES CARE

Risk factors for hospital readmission of elderly patients

(2012) Carlotta Franchi et al.   European Journal of Internal Medicine

A Review of Diabetes Treatment Adherence and the Association with Clinical and Economic Outcomes

(2011) Carl Asche et al.   CLINICAL THERAPEUTICS

Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study

(2011) Tina Ken Schramm et al.   EUROPEAN HEART JOURNAL

Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study

(2011) Alessandro Nobili et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Fixed-dose combination therapies in the management of hyperglycaemia in Type 2 diabetes: an opportunity to improve adherence and patient care

(2010) G. Schernthaner   DIABETIC MEDICINE

Trends in All-Cause and Cardiovascular Disease Mortality Among Women and Men With and Without Diabetes Mellitus in the Framingham Heart Study, 1950 to 2005

(2009) Sarah Rosner Preis et al.   CIRCULATION

Medikamentöse antihyperglykämische Therapie des Diabetes mellitus Typ 2

(2009) S. Matthaei et al.   Diabetologie und Stoffwechsel

Diabetic Patients' Medication Underuse, Illness Outcomes, and Beliefs About Antihyperglycemic and Antihypertensive Treatments

(2008) J. E. Aikens et al.   DIABETES CARE